MedPath
FDA Approval

venlafaxine hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 28, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Venlafaxine(150 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Zydus Lifesciences Limited

918596198

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Zydus Lifesciences Limited

Zydus Lifesciences Limited

Zydus Lifesciences Limited

918596198

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

venlafaxine hydrochloride

Product Details

NDC Product Code
65841-753
Application Number
ANDA090174
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 28, 2023
Code: 7D7RX5A8MOClass: ACTIMQuantity: 150 mg in 1 1
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
CETOSTEARYL ALCOHOLInactive
Code: 2DMT128M1SClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)Inactive
Code: P2OM2Q86BIClass: IACT

venlafaxine hydrochloride

Product Details

NDC Product Code
65841-752
Application Number
ANDA090174
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 28, 2023
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: 7D7RX5A8MOClass: ACTIMQuantity: 75 mg in 1 1
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)Inactive
Code: P2OM2Q86BIClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
CETOSTEARYL ALCOHOLInactive
Code: 2DMT128M1SClass: IACT

venlafaxine hydrochloride

Product Details

NDC Product Code
65841-751
Application Number
ANDA090174
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 28, 2023
Code: 7D7RX5A8MOClass: ACTIMQuantity: 37.5 mg in 1 1
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
CETOSTEARYL ALCOHOLInactive
Code: 2DMT128M1SClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)Inactive
Code: P2OM2Q86BIClass: IACT
© Copyright 2025. All Rights Reserved by MedPath